Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab

被引：0
|
作者：
Muhammet Ali Kaplan
Hamza Ertugrul
Ugur Firat
Mehmet Kucukoner
Ali İnal
Zuhat Urakci
Zafer Pekkolay
Abdurrahman Isikdogan
机构：
[1] Dicle University School of Medicine,Department of Medical Oncology
[2] Dicle University School of Medicine,Department of Internal Medicine
[3] Dicle University School of Medicine,Department of Pathology
来源：
Breast Cancer | 2015年 / 22卷
关键词：
Breast cancer; Brain metastasis; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 509
页数：6
相关论文
共 50 条
  • [21] Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
    F Carabantes-Ocón
    E Saez-Lara
    L Burgos-Garcia
    E Villar-Chamorro
    A Casaus-Hazañas
    S Luna
    C Martínez
    Breast Cancer Research, 9
  • [22] Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
    Iwata, Hiroji
    Xu, Binghe
    Kim, Sung-Bae
    Chung, Wei-Pang
    Park, Yeon Hee
    Kim, Min Hwan
    Tseng, Ling-Ming
    Chung, Chi-Feng
    Huang, Chiun-Sheng
    Kim, Jee Hyun
    Chiu, Joanne Wing Yan
    Yamashita, Toshinari
    Li, Wei
    Egorov, Anton
    Nishijima, Soichiro
    Nakatani, Shunsuke
    Nishiyama, Yuji
    Sugihara, Masahiro
    Cortes, Javier
    Im, Seock-Ah
    CANCER SCIENCE, 2024, 115 (09) : 3079 - 3088
  • [23] Duration of trastuzumab in patients with HER2-positive metastatic breast cancer in prolonged remission
    Haq, R.
    Gulasingam, P.
    CURRENT ONCOLOGY, 2016, 23 (02) : 91 - 95
  • [24] Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases
    Okita, Yoshiko
    Narita, Yoshitaka
    Suzuki, Tsuyoshi
    Arita, Hideyuki
    Yonemori, Kan
    Kinoshita, Takayuki
    Fujiwara, Yasuhiro
    Tsuda, Hitoshi
    Komoike, Yoshifumi
    Nakagawa, Hidemitsu
    Tamaki, Yasuhiro
    Tomita, Yasuhiko
    Shibui, Soichiro
    Maruno, Motohiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (06) : 995 - 1001
  • [25] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Hiroaki Kurihara
    Akinobu Hamada
    Masayuki Yoshida
    Schuichi Shimma
    Jun Hashimoto
    Kan Yonemori
    Hitomi Tani
    Yasuji Miyakita
    Yousuke Kanayama
    Yasuhiro Wada
    Makoto Kodaira
    Mayu Yunokawa
    Harukaze Yamamoto
    Chikako Shimizu
    Kazuhiro Takahashi
    Yasuyoshi Watanabe
    Yasuhiro Fujiwara
    Kenji Tamura
    EJNMMI Research, 5
  • [26] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Kurihara, Hiroaki
    Hamada, Akinobu
    Yoshida, Masayuki
    Shimma, Schuichi
    Hashimoto, Jun
    Yonemori, Kan
    Tani, Hitomi
    Miyakita, Yasuji
    Kanayama, Yousuke
    Wada, Yasuhiro
    Kodaira, Makoto
    Yunokawa, Mayu
    Yamamoto, Harukaze
    Shimizu, Chikako
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    EJNMMI RESEARCH, 2015, 5
  • [27] Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
    R Y Tsang
    R S Finn
    British Journal of Cancer, 2012, 106 : 6 - 13
  • [28] Treatment of brain metastases of HER2-positive breast cancer
    Heudel, P.
    Tredan, O.
    Cassier, P.
    Ray-Coquard, I.
    Guastalla, J. -P.
    Bachelot, T.
    ONCOLOGIE, 2012, 14 (01) : 41 - 44
  • [29] Appearance and therapy of brain metastases in patients with HER2-positive breast cancer
    Witzel, I
    Hemminger, G.
    Ihnen, M.
    Jaenicke, F.
    Mueller, V
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S137 - S137
  • [30] Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies
    Garcia-Alvarez, Alejandro
    Papakonstantinou, Andri
    Oliveira, Mafalda
    CANCERS, 2021, 13 (12)
12345